270 related articles for article (PubMed ID: 22008564)
1. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.
Wood PL; Khan MA; Smith T; Ehrmantraut G; Jin W; Cui W; Braverman NE; Goodenowe DB
Lipids Health Dis; 2011 Oct; 10():182. PubMed ID: 22008564
[TBL] [Abstract][Full Text] [Related]
2. Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
Wood PL; Smith T; Lane N; Khan MA; Ehrmantraut G; Goodenowe DB
Lipids Health Dis; 2011 Dec; 10():227. PubMed ID: 22142382
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata.
Fallatah W; Smith T; Cui W; Jayasinghe D; Di Pietro E; Ritchie SA; Braverman N
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31862688
[TBL] [Abstract][Full Text] [Related]
4. Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction.
Wood PL; Smith T; Pelzer L; Goodenowe DB
Lipids Health Dis; 2011 Jun; 10():102. PubMed ID: 21682894
[TBL] [Abstract][Full Text] [Related]
5. A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.
Braverman N; Zhang R; Chen L; Nimmo G; Scheper S; Tran T; Chaudhury R; Moser A; Steinberg S
Mol Genet Metab; 2010 Apr; 99(4):408-16. PubMed ID: 20060764
[TBL] [Abstract][Full Text] [Related]
6. Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.
Brites P; Ferreira AS; da Silva TF; Sousa VF; Malheiro AR; Duran M; Waterham HR; Baes M; Wanders RJ
PLoS One; 2011; 6(12):e28539. PubMed ID: 22163031
[TBL] [Abstract][Full Text] [Related]
7. Leukodystrophy caused by plasmalogen deficiency rescued by glyceryl 1-myristyl ether treatment.
Malheiro AR; Correia B; Ferreira da Silva T; Bessa-Neto D; Van Veldhoven PP; Brites P
Brain Pathol; 2019 Sep; 29(5):622-639. PubMed ID: 30667116
[TBL] [Abstract][Full Text] [Related]
8. Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation.
Noguchi M; Honsho M; Abe Y; Toyama R; Niwa H; Sato Y; Ghaedi K; Rahmanifar A; Shafeghati Y; Fujiki Y
J Hum Genet; 2014 Jul; 59(7):387-92. PubMed ID: 24849933
[TBL] [Abstract][Full Text] [Related]
9. The importance of ether-phospholipids: a view from the perspective of mouse models.
da Silva TF; Sousa VF; Malheiro AR; Brites P
Biochim Biophys Acta; 2012 Sep; 1822(9):1501-8. PubMed ID: 22659211
[TBL] [Abstract][Full Text] [Related]
10. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors.
Schrakamp G; Schalkwijk CG; Schutgens RB; Wanders RJ; Tager JM; van den Bosch H
J Lipid Res; 1988 Mar; 29(3):325-34. PubMed ID: 3379344
[TBL] [Abstract][Full Text] [Related]
11. A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform.
Barøy T; Koster J; Strømme P; Ebberink MS; Misceo D; Ferdinandusse S; Holmgren A; Hughes T; Merckoll E; Westvik J; Woldseth B; Walter J; Wood N; Tvedt B; Stadskleiv K; Wanders RJ; Waterham HR; Frengen E
Hum Mol Genet; 2015 Oct; 24(20):5845-54. PubMed ID: 26220973
[TBL] [Abstract][Full Text] [Related]
12. Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.
Malheiro AR; da Silva TF; Brites P
J Inherit Metab Dis; 2015 Jan; 38(1):111-21. PubMed ID: 25432520
[TBL] [Abstract][Full Text] [Related]
13. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.
Dorninger F; Brodde A; Braverman NE; Moser AB; Just WW; Forss-Petter S; Brügger B; Berger J
Biochim Biophys Acta; 2015 Feb; 1851(2):117-28. PubMed ID: 25463479
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3.
Itzkovitz B; Jiralerspong S; Nimmo G; Loscalzo M; Horovitz DD; Snowden A; Moser A; Steinberg S; Braverman N
Hum Mutat; 2012 Jan; 33(1):189-97. PubMed ID: 21990100
[TBL] [Abstract][Full Text] [Related]
15. Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination.
da Silva TF; Eira J; Lopes AT; Malheiro AR; Sousa V; Luoma A; Avila RL; Wanders RJ; Just WW; Kirschner DA; Sousa MM; Brites P
J Clin Invest; 2014 Jun; 124(6):2560-70. PubMed ID: 24762439
[TBL] [Abstract][Full Text] [Related]
16. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata.
Brites P; Motley AM; Gressens P; Mooyer PA; Ploegaert I; Everts V; Evrard P; Carmeliet P; Dewerchin M; Schoonjans L; Duran M; Waterham HR; Wanders RJ; Baes M
Hum Mol Genet; 2003 Sep; 12(18):2255-67. PubMed ID: 12915479
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders.
De Biase I; Yuzyuk T; Cui W; Zuromski LM; Moser AB; Braverman NE
Clin Chim Acta; 2023 Mar; 542():117295. PubMed ID: 36914043
[TBL] [Abstract][Full Text] [Related]
18. Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations.
Dranchak PK; Di Pietro E; Snowden A; Oesch N; Braverman NE; Steinberg SJ; Hacia JG
J Cell Biochem; 2011 May; 112(5):1250-8. PubMed ID: 21465523
[TBL] [Abstract][Full Text] [Related]
19. Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata.
Kanzawa N; Shimozawa N; Wanders RJ; Ikeda K; Murakami Y; Waterham HR; Mukai S; Fujita M; Maeda Y; Taguchi R; Fujiki Y; Kinoshita T
J Lipid Res; 2012 Apr; 53(4):653-63. PubMed ID: 22253471
[TBL] [Abstract][Full Text] [Related]
20. Lethal form of chondrodysplasia punctata with normal plasmalogen and cholesterol biosynthesis.
Kumada S; Hayashi M; Kenmochi J; Kurosawa S; Shimozawa N; Kratz LE; Kelley RI; Taki K; Okaniwa M
Am J Med Genet; 2001 Jan; 98(3):250-5. PubMed ID: 11169563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
